⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6433951 | 0.74 | — | — | |
| SCHEMBL813821 | 0.67 | — | — | |
| SCHEMBL787874 | 0.67 | — | — | |
| SCHEMBL290983 | 0.65 | — | — | |
| SCHEMBL1148834 | 0.65 | — | — | |
| SCHEMBL15359393 | 0.64 | — | — | |
| SCHEMBL10979113 | 0.62 | — | — | |
| SCHEMBL23302398 | 0.61 | — | — | |
| SCHEMBL4691298 | 0.61 | — | — | |
| SCHEMBL2889249 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6995 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024093907-A1 | LIGAND FOR DELIVERING SIRNA TO EYE AND CENTRAL NERVOUS SYSTEM | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| WO-2024093947-A1 | PRODRUG FOR DELIVERING SIRNA INTO CELL | 大睿生物医药科技(上海)有限公司 | 2024-05-10 | — | — | WO | claimed |
| EP-2991655-B1 | COMPOSITIONS AND METHODS FOR ALTERING SECOND MESSENGER SIGNALING | MEMORIAL SLOAN KETTERING CANCER CENTER (US) | 2024-04-10 | — | — | EP | claimed |
| EP-3606528-B1 | TRICYCLIC COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 (GSK3) INHIBITORS AND USES THEREOF | BROAD INST INC (US) | 2023-10-18 | — | — | EP | claimed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | claimed |
| US-11241435-B2 | Uses of salt-inducible kinase (SIK) inhibitors for treating osteoporosis | THE GENERAL HOSPITAL CORPORATION (US) | 2022-02-08 | — | — | US | claimed |
| EP-3172213-B1 | MACROCYCLIC KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2021-09-22 | — | — | EP | claimed |
| EP-3092220-B1 | VITAMIN C PRODRUGS AND USES THEREOF | UNIV FLORIDA (US) | 2021-01-20 | — | — | EP | claimed |
| US-10870651-B2 | Inhibitors of cyclin-dependent kinase 7 (CDK7) | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2020-12-22 | — | — | US | claimed |
| EP-3171874-B1 | IMIDAZOLYL KINASE INHIBITORS AND USES THEREOF | DANA FARBER CANCER INST INC (US) | 2020-11-18 | — | — | EP | claimed |
| EP-0545912-A2 | 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1993-06-09 | — | — | EP | claimed |
| WO-1993006079-A1 | PREPARATION OF SUBSTITUTED ISOSERINE ESTERS USING METAL ALKOXIDES AND β-LACTAMS | FLORIDA STATE UNIVERSITY (US) | 1993-04-01 | — | — | WO | claimed |
| WO-1993006094-A1 | METAL ALKOXIDES | FLORIDA STATE UNIVERSITY (US) | 1993-04-01 | — | — | WO | claimed |
| US-5175315-A | Reacting with alcohol in presence of altivating agent | FLORIDA STATE UNIVERSITY (US) | 1992-12-29 | — | — | US | claimed |
| EP-0503785-A1 | 1-Biphenylimidazole derivatives, their preparation and their therapeutic use | Sankyo Company Limited (JP) | 1992-09-16 | — | — | EP | claimed |
| US-5136060-A | Reacting with alcohol | FLORIDA STATE UNIVERSITY (US) | 1992-08-04 | — | — | US | claimed |
| US-5126267-A | Protected hydroxy method for alcohol-ester separation | EASTMAN KODAK COMPANY (US) | 1992-06-30 | — | — | US | claimed |
| EP-0428376-A1 | Method for preparation of taxol using an oxazinone | FLORIDA STATE UNIVERSITY (US) | 1991-05-22 | — | — | EP | claimed |
| US-5015744-A | Esterification of an alcohol with an oxazinone | FLORIDA STATE UNIVERSITY (US) | 1991-05-14 | — | — | US | claimed |
| EP-0400971-A2 | Method for preparation of taxol | FLORIDA STATE UNIVERSITY (US) | 1990-12-05 | — | — | EP | claimed |